glyconetBB : A Public-Private Network from Berlin-Brandebourg and Beyond

glyconetBB is a public-private partnership, of the glycobiology stakeholders in the region of Berlin-Brandenburg.

Glycoscience research in Berlin Brandenburg spans for more than a decade. First attempts to build upon the fragmented expertise and create a value chain for glycosciences in the region can be traced back to the beginning of the 2000s. Today, with combined excellence of the Max-Planck-Institute for Colloids and Interfaces (MPIKG), Fraunhofer Gesellschaft für Zellbiologie und Immunologie (FhG IZI) Abteilung Potsdam-Golm, Charite Universitätsmedizin and a great variety of SMEs like Scienion AG, Glycotope, AnalytiCon Discovery or MicroDiscovery, bearing the expertise in glycan isolation, glycan synthesis, glycan-engineering, glycan-microarrays production, analysis and high-throughput screenings, the region established itself as one of the leading centers for glycosciences in Europe with a unique value added chain in glycobiology. As a result of the synergy of regional players, a new glycobiology network featuring world renowned scientists and entrepreneurs was initiated : glyconet Berlin Brandenburg (glyconetBB). Focused on health applications of glycomics, like drug development and new diagnostics, the research in the region follows the shift in health sciences towards the prevention and early diagnosis, still providing for the cure if the disease strike.
Email :